Clinical Trials · NCT07801820
Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes Mellitus
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Shanghai Minwei Biotechnology Co., Ltd
- Enrollment
- 240
- Start date
- Jun 2026
- Locations
- 1 site, China
- Primary endpoint
- Change in Glycated Hemoglobin (HbA1c) from Baseline at Week 20 Compared to Placebo